Abel Hall LLC
PBYI icon

Abel Hall LLC’s Puma Biotechnology PBYI Stock Holding History

Abel Hall LLC’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$114K Hold
11,520
– – 0.02% 766
2026
Q2 		$93.4K Buy
11,520
+46
+0.4% +$337 0.02% 846
2026
Q1 		$73.3K Buy
11,474
+681
+6% +$4.39K 0.02% 714
2025
Q4 		$64.2K Buy
+10,793
New +$57.3K 0.02% 639

Other funds holding PBYI

Haven Private
Haven Private Orlando, Florida $253M AUM 14.52% 1-Year Est. Return
OpenArc Corporate Advisory
OpenArc Corporate Advisory Atlanta, Georgia $8.86B AUM 19.31% 1-Year Est. Return
SummerHaven Investment Management
SummerHaven Investment Management Stamford, Connecticut $179M AUM 57.61% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Evergreen Capital Management
Evergreen Capital Management Bellevue, Washington $5.65B AUM 21.62% 1-Year Est. Return
Vise Technologies
Vise Technologies New York $12B AUM 18.78% 1-Year Est. Return
Kathmere Capital Management
Kathmere Capital Management Wayne, Pennsylvania $2.07B AUM 20.3% 1-Year Est. Return
Baron Wealth Management
Baron Wealth Management Troy, Michigan $389M AUM 21.95% 1-Year Est. Return
C2C Wealth Management
C2C Wealth Management Scottsdale, Arizona $128M AUM 19.37% 1-Year Est. Return

Abel Hall LLC's PBYI Position: Q3 2026 in Review

Abel Hall LLC held its Puma Biotechnology (PBYI) position steady in Q3 2026 at 11,520 shares worth $114K. The position accounts for 0.02% of the portfolio, ranked #766.

Abel Hall LLC first reported a position in PBYI in Q4 2025 and has held it in 4 quarters since. 37 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.

  • Abel Hall LLC held 11,520 shares of Puma Biotechnology worth $114K as of Q3 2026.
  • Abel Hall LLC left its Puma Biotechnology share count unchanged in Q3 2026.
  • Puma Biotechnology made up 0.02% of Abel Hall LLC's portfolio in Q3 2026, its #766 holding.
  • Abel Hall LLC first reported a position in Puma Biotechnology in Q4 2025 and has held it in 4 quarters since.
  • 37 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.

Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.